Michael Saunders

Title: Michael Saunders: Innovator in Antibody Research

Introduction

Michael Saunders is a notable inventor based in Ostwald, France. He has made significant contributions to the field of antibody research, particularly in the development of antibodies specific for the retinoic acid receptor-gamma. His work has implications for understanding tissue-specific expression patterns of various isoforms of this receptor.

Latest Patents

Michael Saunders holds a patent for "Antibodies specific for retinoic acid receptor-gamma." This invention discloses methods for preparing antibodies that bind to specific isoforms of the human retinoic acid receptor-gamma (RAR-gamma). The patent describes several monoclonal antibodies that bind to human RAR-gamma, but not to mouse, or that bind to RAR-gamma1, but not to RAR-gamma2. Additionally, methods and kits are provided to detect the isotype of RAR-gamma expressed in test samples, which are useful for determining the tissue-specific expression patterns of various RAR-gamma isoforms.

Career Highlights

Throughout his career, Michael has worked with prestigious institutions, including Université Louis Pasteur Strasbourg I and the National Institute of Health and Medical Research. His research has contributed to advancements in the understanding of retinoic acid receptors and their role in various biological processes.

Collaborations

Michael has collaborated with notable colleagues such as Isabelle Scheuer and Yves Lutz. Their combined expertise has furthered the research in the field of antibody development and receptor studies.

Conclusion

Michael Saunders is a distinguished inventor whose work in antibody research has paved the way for new methods in detecting and understanding retinoic acid receptor isoforms. His contributions continue to impact the scientific community and enhance our knowledge of receptor biology.